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OXYGEN-DERIVED FREE RADICALS AND THE PATHOGENESIS OF 
CATECHOLAMINE CARDIOMYOPATHY. Valerie L. Ward and S. Evans 
Downing. Department of Cardiovascular Pathology, Yale University 
School of Medicine, New Haven, CT. 
Oxygen-derived free radicals have been proposed as a potential 
mechanism in the pathogenesis of catecholamine cardiomyopathy. 
Direct evidence for this hypothesis has not been forthcoming, 
however previous studies have explored myocardial sources for 
oxyradical formation, decreased ischemia-reperfusion injury by 
myocardial pretreatment with antioxidants, and cardioprotection by 
the xanthine oxidase inhibitor, allopurinol, in a rabbit model of 
catecholamine cardiomyopathy. These studies have suggested a role 
for oxyradicals in myocardial injury. This present study was 
undertaken to examine functional, biochemical, and histological 
evidence for oxyradical-mediated damage when norepinephrine (NE), 
a potent catecholamine, is infused into the rabbit myocardium. If the 
characteristic NE myocardial damage were prevented when NE was 
given together with an antioxidant, then this cardioprotection would 
provide evidence for a role for oxyradicals in the pathogenesis of the 
catecholamine cardiomyopathy. Four groups of rabbits were tested. 
Group 1 was infused with normal saline for 90 minutes and served 
as the control group. Group 2 was infused with NE (3 ug/min/kg) for 
90 minutes. Group 3 was infused with the antioxidants superoxide 
dismutase (5 mg/kg/hr, SOD) and catalase (10 mg/kg/hr) 
simultaneously with a 90 minute infusion of NE (3u g/m i n/kg). 
Group 4 was pretreated with oxypurinol (20 mg/kg over 10 minutes) 

and then 5 minutes later, NE (3 ug/min/kg) was infused for 90 
minutes. The rabbit hearts were excised 48 hours after the infusion, 
and hung on an isolated Langendorff perfusion apparatus. Peak 
systolic pressure tended to be lower in all NE treated hearts 
(although not significantly); hence it was not improved by the 
presence of antioxidants. The maximum rate of rise of left 
ventricular pressure (+dP/dt, i.e. contractility) did not differ 
significantly between the groups. However, the rate of relaxation (- 
dP/dt) did differ significantly between the the saline control group 
and both the NE group and NE + OXY group. Therefore, NE 
demonstrated negative effects on left ventricular relaxation. These 
effects were not prevented by the addition of antioxidants. 
Myocardial oxygen consumption and coronary flow were decreased 
in all of the NE treated groups, while oxygen extraction was 
unchanged. The NE + OXY group showed significantly lower 
concentrations of the high energy phosphates adenosine triphosphate 
(ATP) and creatine phosphate than did the NE group. Myocardial 
glycogen concentrations did not differ significantly, although the NE + 
OXY group showed the lowest glycogen content. Histologic evidence 
of NE-induced injury was present in all NE treated groups. Injury to 
the myocardium was most severe in the NE + OXY group. This study 
provides evidence against a role for oxyradicals in the pathogenesis 
of catecholamine cardiomyopathy. Hence, the mechanistic basis for 
this process remains to be established. 
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myocardium is infiltrated by mononuclear cells rather than 
polymorphonuclear cells (Reichenbach & Benditt, 1970). This 
delayed model of myocardial injury raises the possibility for injury 
occurring even after the initial ischemic insult, and hence is 
suggestive of the mechanism of injury that is proposed in the model 
of ischemia-reperfusion in canine hearts (Jiang & Downing, 1990). In 
the latter, oxyradicals have been implicated as the mediators of the 
injury which occurs at the time the ischemic myocardium is 
reperfused with oxygenated blood (Downey & Yellon, 1992). 
Common antioxidants (free radical scavenging agents) such as 
superoxide dismutase, catalase, allopurinol, and oxypurinol have 
been used to pretreat the canine myocardium and prevent or reduce 
reperfusion injury (Downey & Yellon, 1992). 
Pretreatment with allopurinol, a xanthine oxidase inhibitor, 
protects rabbit myocardium from the NE-induced myocardial damage 
(Jiang et al., 1991). A possible mechanism for allopurinol protection 
of the rabbit heart may be the direct scavenging of oxyradicals (Jiang 
et al., 1991). Therefore, the present study was undertaken to obtain 
direct evidence for the involvement of oxyradicals in the 
pathogenesis of the catecholamine cardiomyopathy. Rabbits were 
infused with a combination of antioxidants (superoxide dismutase 
and catalase) along with a 90 minute NE infusion. The xanthine 
oxidase inhibitor, oxypurinol, was also used to pretreat rabbits to 
determine if it was equally or more effective than allopurinol. 
Oxypurinol is the first metabolite of allopurinol and thought to be a 
more potent compound than allopurinol (Puett et al., 1987 and 





Norepinephrine (levarterenol, 1-noradrenaline, NE) is a 
neurotransmitter released from postganglionic sympathetic nerves 
(Gilman et al., 1990). The concentration of NE in the adrenal medulla 
is approximately 10-20% of the total catecholamine concentration 
while its concentration in a pheochromocytoma, a tumor of the 
adrenal medulla, approaches 97% (Gilman et al., 1990). NE is a 
potent alpha receptor agonist and it is a weak beta2 receptor agonist 
(Gilman et al., 1990). NE has been used clinically as a therapy for 
shock (Schenk & Moss, 1966 and Gilman et al., 1990). NE bitartrate 
(levophed bitartrate) is a water-soluble, cystalline monohydrate salt 
preparation infused intravenously as a solution containing 4 ug/ml of 
NE base until the desired pressor response is attained (Gilman et al., 
1990). An infusion of 2 to 4 ug of NE base/minute is adequate to 
treat hypotension (Gilman et al., 1990). 
NE infusion results in histological changes on the myocardium 
(Schenk & Moss, 1966). The dose of NE that is sufficient to induce NE 
myocardial changes in an animal model was studied in an early 
experiment (Schenk & Moss, 1966). In rabbits, a dose range of 1.5 to 
3 ug/kg/min was sufficient to cause characteristic NE-induced 
myocardial lesions within one hour after the start of an infusion 
(Schenk & Moss, 1966). These dosages in the rabbit provide an 
accurate histopathological model of the catecholamine 
cardiomyopathy in which biologic variability is not excessive (Schenk 




In 1958, one of the earliest accounts of the histological effects 
of NE on the myocardium was published by Szakacs and Cannon, at 
the U.S. Naval Medical School, in the American Journal of Clinical 
Pathology. These researchers made a clinical-pathological correlation 
between navy personnel who were administered a continuous 
intravenous therapeutic infusion of NE in instances of shock, and the 
subsequent death of these personnel with autopsy findings of a 
nonspecific myocarditis (Szakacs & Cannon, 1958). Myocardial 
autopsy findings were characterized by "Perivascular myocarditis, 
manifested by myofibrillar degeneration and fragmentation, brick- 
red staining of the myofibrils, polymorphonuclear and myocytes 
infiltrate and edema..." 1. These early researchers commented that 
the clinical practice of infusing large amounts of NE for extended 
periods of time usually resulted in therapeutic failures (Szakacs & 
Cannon,1958). However, from a pathophysiological standpoint, this 
clinical practice led to the correlation between cardiac autopsy 
findings in the above mentioned personnel and similar autopsy 
findings in patients with a tumor secreting excess amounts of NE 
(Szakacs & Cannon, 1958). 
A pheochromocytoma, a tumor of the adrenal medulla, is 
composed of chromaffin cells which are derived embryologically 
from the neural crest (Sheps et al., 1990). These cells are able to 
synthesize, store, and secrete large quantities of catecholamines, 
1LT. Jcno E. Szakacs and LT. CDR. ALbert Cannon. "1-Norcpinephrine 
Myocarditis." Am. J. Clin. Pathol. 1958; 30: p. 426. 
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usually NE (Sheps et al., 1990). At autopsy, hearts of 
pheochromocytoma patients show a "Myocarditis...!with microscopic 
changes consisting of] edema, chronic inflammatory cells, and fibrosis 
replacing the myofibrils. "2 Furthermore, Szakacs and Cannon 
provided an experimental dog-model of this NE-induced nonspecific 
myocarditis. They infused 11 dogs, via cannulated external jugular 
veins, with physiological levels of NE (ranging from 0.8 to 2.8 
ug/kg/min) for a maximum of 16 days. Hematoxylin and eosin 
stained microscopic sections of these dog hearts revealed 
...multiple focal lesions without an apparent 
preferential distribution. Endocardial 
proliferation, thickening, and edema 
accompanied the hemorrhages. The 
myocardial lesions manifested edema, 
degenerating myofibrils, and cellular 
infiltration...The arterial and arteriolar walls 
manifested marked degenerative and, in 
extreme cases, necrotic changes with 
periarterial reaction.3 
Interestingly, Szakacs and Cannon provided valuable clinical- 
pathological information, in that they were able to experimentally 
reproduce a pathophysiological effect of a pheochromocytoma on the 
myocardium. These researchers concluded that the clinical practice 
of NE infusion for shock should be reassessed in light of the 
untoward cardiac effects of NE (Szakacs and Cannon, 1958). 
Furthermore, these authors speculated that the actual pathogenesis 
-Szakacs & Cannon, 1958, p. 426. 
^Szakacs & Cannon, 1958, p. 432. 
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of the cardiac lesions secondary to NE infusion is probably not simple 
(Szakacs and Cannon, 1958). It is this speculation that brings this 
1958 paper up to the current status of 1993 research in the field of 
NE-induced myocarditis. 
Since this early work on NE myocarditis, autopsy findings of 
patients who have died from (1) pheochromocytoma, (2) 
complications of cardiovascular surgery (for example, low cardiac 
output syndrome), and (3) subarachnoid hemorrhage have provided 
further histopathology regarding the NE lesion in humans 
(Reichenbach, 1970). The lesion is characterized by myofibrillar 
degeneration (Reichenbach & Benditt, 1970). In the myocardial cell, 
there is 
...loss of definition of the linear arrangement 
of myofibrils with cross striations and the 
appearance of areas of dense eosinophilic 
transverse banding, alternating with lighter 
staining granular zones within the 
cytoplasm...This characteristic becomes less 
prominent with the passage of time as 
macrophages infiltrate and phagocytose 
necrotic cell debris.4 
In the interstitium, 
Polymorphonuclear leukocytes 
surrounding the injured myocardial cells are 
scarce or absent and in contrast to what 
occurs in myocardial infarction never become 
prominent among the cells reacting in this 
4Dennis D. Reichenbach and Earl P. Benditt, "Catecholamines and 
Cardiomyopathy: The Pathogenesis and Potential Importance of Myofibrillar 
Degeneration." Human Pathology 1970; 1; p. 127. 
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injury. In the interstitial region a 
proliferative response is evident from about 
the 2nd to 8th day following injury. The cells, 
which are interspersed between the necrotic 
myocardial cells, have plump oval nuclei and 
small nucleoli; they may represent endothelial 
cells, fibroblasts, or 
histiocytes...Macrophages infiltrate the 
area of injury, and by the end of the first 
week the majority of the necrotic myocardial 
cells have been largely removed by 
phagocytosis.-4’ 
In sum, the unifying characteristics of this lesion are myofibrillar 
degeneration and macrophage infiltration (Reichenbach & Benditt, 
1970). 
NOREPINEPHRINE HEMODYNAMICS 
In addition to the morphological effects of NE on the 
myocardium, the infusion of NE has characteristic hemodynamic 
effects on the cardiovascular system. In 1966, Moss et al. looked at 
the hemodynamic changes of NE infusion at physiologic doses in dogs. 
NE was infused into three groups of dogs at varying concentrations 
that is 1 ug/kg/min, 2 ug/kg/min, and 4 ug/kg/min in 5% dextrose 
in water (Moss et al., 1966). During the infusion, the first derivative 
of the pressure recorded in the left ventricle provided a measure of 
the rate of rise of left ventriculalr pressure with time (dLV/dt or 
dP/dt), and electrocadiographic (EKG) recordings in lead II were 
Reichenbach & Benditt, 1970, p. 129. 
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recorded (Moss et al., 1966). The pertinent hemodynamic results of 
this study are as follows: 
Neither the hemodynamic parameters nor the 
electrocardiogram changed significantly in 
[the control group]. In groups [receiving 1, 2, 
and 4 ug/kg/min of NE] the initial increase in 
[systemic arterial pressure and] 
dLV/dt...during the first 15 minutes of NE 
administration was not sustained, and a 
progressive dose-related decline in these 
parameters was observed during the 
remaining three and three-quarter hours of 
the infusion period.6 
Furthermore, the EKG recording of heart rate in the groups 
infused with NE showed an initial bradycardia (at time = 15 
minutes), and then a "progressive tachycardia.This study by Moss 
et al. provides the background hemodynamic information essential to 
the assessment of NE infusion cardiovascular effects in an animal 
model.^ 
^Arthur J. Moss, Ingvar Vittands, and Eric A. Schenk, "Cardiovascular Effects 
of Sustained Norepinephrine Infusions. 1. Hemodynamics." Circulation 
Research 1966; 18: p. 597. 
7Moss et al., 1966, p. 600. 
^In this thesis of NE-induced cardiomyopathy in a rabbit model, specific 
hemodynamic parameters were measured in order to document the 
characteristic findings during the infusion of NE. These parameters include 
mean arterial pressure and heart rate. The first derivative of the left 
ventricular pressure (dLV/dt or dP/dt) was not measured during the infusion 
of NE, instead it was measured 48 hours after NE infusion while the rabbit 
hearts were being perfused as isolated hearts on the Langendorff apparatus. 
However, the effects of NE infusion on dP/dt may be comparable. Therefore, 
in the paper by Moss, only the hemodynamic findings most pertinent to this 
thesis were discussed. 
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EXPERIMENTAL DATED HOI, A MINE CARDIOMYOPATHY 
The pathogenesis of the catecholamine cardiomyopathy is 
presently unknown (Downing & Lee, 1978 and Jiang et al., 1991). 
Much has been learned by studying the effects of pretreatment with 
different drugs on the experimentally-induced catecholamine 
cardiomyopathy in the rabbit model. An early study in this 
laboratory was a modification of the work done by Schenk and Moss 
(1966) in the rabbit model which is readily reproducible. Rabbits 
were infused with NE at a rate of 3ug/min/kg for 90 minutes and 
severe cardiomyopathic damage resulted (Downing & Lee, 1978). 
Insulin (5 units/kg or 10 units/kg) given prior to a 90 min infusion 
with NE (2 ug/min/kg, i.v.), in an intact rabbit model, decreases the 
frequency of advanced NE-induced myocardial lesions seen at 48 
hours post-infusion (Downing & Lee, 1978). A correlation between 
the extent of ventricular dysfunction and the severity of 
cardiomyopathic findings has been demonstrated (Werner et al., 
1980). These initial studies with insulin led to further pretreatment 
experiments that have revealed more information about the 
pathogenesis of the catecholamine cardiomyopathy. 
In addition to the histological alterations and pathogenesis of 
the catecholamine cardiomyopathy, this laboratory has also been 
interested in the capacity of the NE-damaged rabbit hearts to 
contract and generate force under normal and stressed conditions 
(Lee & Downing, 1982). Further work with insulin pretreatment of 
the rabbit myocardium revealed that those that received insulin did 
not experience the significant and persistent impairment of left 
ventricular function (specifically a decreased capacity to respond to 

afterload stress) as did rabbits that were not pretreated with insulin 
prior to NE (Werner et al., 1980). This study with insulin suggested 
a relationship between inotropic stimulation and the catecholamine 
cardiomyopathy (Downing & Lee, 1983). Therefore a subsequent 
study explored the inotropic responsiveness of cardiomyopathic 
hearts. Contractility (dP/dtmax = maximal rate of rise of left 
ventricular pressure) of the hearts was measured at increasing NE 
doses and dose-response curves were plotted (Fripp et al., 1981). 
The cardiomyopathic rabbits demonstrated a sharply decreased 
ability to improve contractility as compared with normal controls 
(Fripp et al., 1981). Subsequent studies assessed left ventricular 
function through the use of preload curves obtained by augmenting 
venous return (Lee & Downing, 1982). The findings indicated that 
cardiomyopathic rabbits generate adequate additional force in 
response to NE stimulation, even though velocity (contractility) 
responses are decreased. Therefore, there exists a dissociation 
between pump performance and myocardial contractility (Lee & 
Downing, 1982). 
The fact that NE is both an alpha- and beta-agonist led to 
studies of the effects of the alpha-agonists and antagonists on the 
catecholamine cardiomyopathy (Downing & Lee, 1983). 
Furthermore, the infusion of the alpha-agonist methoxamine over a 
90 min time period led to myocardial injury identical to that seen in 
90 min NE infusions (Downing & Lee, 1983). Intravenous infusion of 
rabbits with the alpha-antagonist phentolamine (10 mg/kg) prior to 
a 90 minute infusion of NE resulted in significantly reduced 
myocardial injury (Downing & Lee, 1983). Hence, it was concluded 

that alpha-receptor stimulation of cardiac myofibers plays a role in 
the myocardial injury seen in the catecholamine cardiomyopathy, 
however the specific mechanisms of injury remained unknown 
(Downing & Lee, 1983). 
The above findings with methoxamine and phentolamine 
prompted a study of the role of coronary artery alpha-receptors in 
the NE cardiomyopathy (Simons & Downing, 1985). It was found that 
NE given in the amounts known to result in cardiomyopathic changes 
produced a significant fall in coronary flow and increased coronary 
resistance (Simons & Downing, 1985). Furthermore, rabbits that 
received both phentolamine and NE infusions did not demonstrate 
coronary vasoconstriction. Instead, phentolamine prevented changes 
in both coronary flow and resistance (Simons & Downing, 1985). 
Similar findings were previously reported in an intact conscious dog 
model of NE (0.1 and 1.0 ug/kg, i.v.) infusion; NE exerted alpha- 
adrenergic vasoconstriction that was prevented in the presence of 
phentolamine (Vatner et al., 1974). 
The foregoing results suggest that an ischemic mechanism may 
contribute to the catecholamine cardiomyopathy (Simons & Downing, 
1985). However, the histopathology of the lesion is that of a 
mononuclear cell infiltrate and not that of polymorphonuclear cells 
that represent acute injury and which are found 2 days after an 
ischemic event (Downing & Chen, 1985). This discrepancy led to the 
hypothesis that the injury leading to the cardiomyopathic lesion may 
not be the acute ischemic insult, but a delayed or chronic type 
(mononuclear infiltration) of injury (Downing & Chen, 1985). 

In subsequent studies it was found that tyramine-stimulated 
endogenous release of catecholamines produces myocardial injury 
that is identical to the previous studies with exogenously 
administered NE (Downing & Chen, 1985). The extent of the 
cardiomyopathic changes is directly related to the amount of 
tyramine given to the rabbit and the resulting plasma catecholamine 
concentrations (Downing & Chen, 1985). Therefore, in addition to 
alpha-receptor mediated coronary vasoconstriction, another possible 
pathogenetic mechanism for the catecholamine cardiomyopathy is 
excessive myocardial adrenergic receptor stimulation (Chen & 
Downing, 1990). 
Studies were undertaken to determine if functional and 
metabolic evidence for myocyte injury would be identifiable 
immediately after completion of the 90 minute NE infusion and 
before the appearance of a leukocytic infiltrate (Chen & Downing, 
1990). At the end of the 90 minute NE infusion, the rabbit hearts 
were excised and studied in an isolated working heart system 
perfused retrogradely with a recirculating red blood cell-enriched 
Krebs-Henseleit bicarbonate buffer from a Langendorff column (Chen 
& Downing, 1990). This study showed reductions in stroke work, 
coronary flow, and glucose and palmitate oxidation in NE injured 
hearts compared with normal saline infused controls. However, 
oxygen delivery and extraction, ATP, creatine phosphate, and 
glycogen concentrations were identical between NE injured hearts 
and normal saline controls (Chen & Downing, 1990). Therefore, it 
was concluded that the metabolic indices could not provide a causal 

explanation for the sharply decreased mechanical performance after 
NE exposure (Chen & Downing, 1990). 
A review of the current literature regarding the pathogenesis 
of the catecholamine cardiomyopathy indicates that the most 
important factors in the pathogenesis include coronary 
vasoconstriction and the free radical hypothesis (Jiang & Downing, 
1990). Coronary vasoconstriction (ischemia) mediated by alpha- 
adrenergic pathways implies acute ischemic injury. However, the 
histopathology of the catecholamine cardiomyopathy is not consistent 
with acute ischemic damage (Jiang & Downing, 1990). The 
myocardial lesion seen 48 hours after catecholamine infusion is 
characterized by a mononuclear cell infiltrate rather than the 
polymorphonuclear cell infiltrate associated with ischemic injury 
(Jiang & Downing, 1990). However, because coronary 
vasoconstriction is followed by reperfusion of previously ischemic 
myocardium, generation of free radicals and subsequent injury may 
occur (Jiang & Downing, 1990). Oxygen-derived free radicals formed 
at the time of reperfusion (rather than injury occurring with acute 
ischemia) are more consistent with the (delayed/chronic) 
mononuclear infiltration. Sources of the free radicals in the 
ischemia-reperfusion model are (a) catecholamine autooxidation, (b) 
mitochondrial respiratory chain, (c) leukocytes and (d) endothelium- 
bound xanthine oxidase (Downey & Yellon, 1992). These sources are 
also plausible for catecholamine cardiomyopathy (Jiang & Downing, 
1990). 
Allopurinol, a xanthine oxidase inhibitor, was examined for its 
cardioprotective effects in the setting of the experimentally-induced 

catecholamine cardiomyopathy (Jiang & Downing, 1990 and Jiang et 
al., 1991). Rabbits were infused intravenously with allopurinol (50 
mg/kg) as a 3 minute pretreatment, then 30 minutes later, 
allopurinol (50 ug/min/kg) and NE (3 ug/min/kg) was infused 
intravenously for 90 minutes (Jiang et al., 1991). After 48 hours, the 
hearts were excised and studied as isolated, isovolumic heart 
preparations perfused retrogradely with a modified Krebs-Henseleit 
buffer (Jiang et al., 1991). Allopurinol decreased myocyte injury and 
preserved mechanical function. There was preservation of adenosine 
triphosphate, creatine phosphate, and glycogen and decreased 
release of creatine phosphokinase and lactic dehydrogenase, and 
increased myocardial oxygen consumption and extraction compared 
with rabbits that received an infusion of NE only (Jiang et al., 1991). 
ISCHEMIA-REPERFUSION INJURY 
Ischemia-reperfusion injury has been defined as the 
reintroduction of oxygen to a hypoxic heart resulting in myocyte 
death (Downey & Yellon, 1992). It is not the ischemia alone that 
causes cell death, rather oxygen-derived free radicals (oxyradicals) 
that are formed in the reperfusion phase contribute to the myocyte 
death (Downey & Yellon, 1992). This hypothesis is supported by the 
cardioprotective effects afforded by antioxidants on ischemic- 
reperfused myocardium (Downey & Yellon, 1992). Several 
experiments with standardized ischemia-reperfusion protocols have 
been undertaken to assess the ability of different antioxidants to 
lessen or prevent myocardial injury (Downey & Yellon, 1992). 
Evidence also exists for the involvement of oxyradicals in the 

catecholamine cardiomyopathy, therefore this idea of a standardized 
experimental protocol and use of a particular antioxidant formed the 
basis for this thesis in the rabbit model. 
OXYGEN-DERIVED FREE, RADICALS (QXYRADICALS) 
The molecular chemistry of an oxyradical is that of a molecule 
with unpaired electrons in its outer shells or orbitals, therefore 
oxyradicals are unstable and prone to reactivity (Downey & Yellon, 
1992 and Halliwell, 1991). Oxyradicals are formed by the reduction 
of molecular oxygen (02) by less than four electrons (Simpson et al., 
1987). 
Molecular oxygen can maximally accept four 
electrons to produce two molecules of water. 
The one-, two-, and three-electron reduction 
of oxygen results in the production of the 
toxic and reactive intermediates, superoxide 
anion, hydrogen peroxide, and hydroxyl 
radical, respectively.^ 
Under normal conditions, oxyradicals are scavenged by an 
endogenous supply of antioxidants (Simpson et al., 1987). 
Endogenous scavenging mechanisms are a prerequisite for aerobic 
life (Sies, 1991). However, under conditions of ischemia-reperfusion, 
an excessive amount of oxyradicals are produced and render the 
endogenous defense mechanisms inadequate (Simpson et al., 1987). 
In the rabbit model, it has been found that there is progressive 
9 Paul J. Simpson, Judith K. Mickelson, and Benedict R. Lucchesi, "Free Radical 
Scavengers in Myocardial Ischemia." Federation Proc. 46: 2411-2421; 1987 p 
2414. 

impairment in endogenous myocardial antioxidants during the 
reperfusion phase (Ko et al., 1990). 
It remains unclear as to which (if not all) of the known 
oxyradicals specifically mediates reperfusion injury or catecholamine 
injury, nor the source of specific oxyradicals, nor which antioxidant is 
best used to scavenge the culprit oxyradical (Kloner et al., 1989 and 
Downey & Yellon, 1992). There are several possible oxyradicals that 
can be implicated in myocardial injury including superoxide anion 
(02-), hydroxyl radical (OH-), and hydrogen peroxide (H2O2) 
(Downey & Yellon, 1992). It is a misnomer to refer to hydrogen 
peroxide as an oxyradical, because its molecular structure is not that 
of a radical, that is there are no unpaired electrons (Bast et al., 1991). 
Instead, it is more accurate to refer to hydrogen peroxide and the 
other "oxyradicals" as reactive oxygen species (Bast et al., 1991). 
The sources of oxyradicals in the ischemic-reperfused heart 
and in the catecholamine cardiomyopathy include (a) catecholamine 
autoxidation, (b) xanthine oxidase, (c) mitochondria, and (d) 
leukocytes (Downey & Yellon, 1992 and Jiang & Downing, 1990). In 
the ischemic myocardium, catecholamines are released in excessive 
quantities from nerve endings, therefore the autoxidation of a 
catecholamine to adrenochrome can lead to the generation of 
oxyradicals (Burton, 1988 and Ferrari et al., 1991). Specifically, the 
infusion of large quantities of catecholamines results in the 
production of catecholamine oxidation products including 
adrenochrome (Yates et al., 1981). Adrenochrome has been shown to 
cause myocardial lesions (including fragmentation of myofibrils and 

disruption of mitochondria and contractile elements) that result in 
decreased contractility in the rat heart (Yates et al., 1981). 
Also, in ischemia, xanthine dehydrogenase is converted to 
xanthine oxidase within the vascular endothelial cells, and 
simultaneously ATP is degraded to hypoxanthine (Ferrari et al., 
1991). Furthermore, 
During ischemia, high-energy phosphate use 
exceeds production and intracellular levels of 
ATP, ADP, creatine phosphate, and the 
adenine nucleotide pool are decreased. 
Metabolic products such as AMP, inosine, 
hypoxanthine, xanthine, and adenosine 
accumulate in the ischemic tissue. 10 
The mechanism by which xanthine oxidase produces oxyradicals 
involves the oxidation of the excessively accumulated hypoxanthine 
which, upon reintroduction of oxygen into the ischemic tissue, results 
in the formation of the superoxide anion and hydrogen peroxide 
(Yellon & Downey, 1990). The chemical reactions are as follows 
(Richard et al., 1990 and Perler et al., 1990): 
iscliem ia---> adenine nucleotides->i no sine-> hypoxanthine 
ischemia--->xanthine dehydrogenase->xanthine oxidase 
hypoxanthine-xanthine oxidase___> xanthine + superoxide anion 
xanthine-xanthine oxidaseurjc acid + superoxide anion 
superoxide anion---> hydroxyl radical 
10 Simpson et al.. p. 2414. 

Another source of oxyradicals in ischemia-reperfusion and the 
catecholamine cardiomyopathy is the cardiac mitochondria. Under 
physiologic conditions, the cardiac mitochondrial respiratory electron 
transport chain produces superoxide anion on the internal 
mitochondrial membrane (Ferrari et al., 1992). However, the 
majority of the superoxide anion is converted by superoxide 
dismutase to hydrogen peroxide and water, and the aerobic 
myocardium is able to survive endogenous oxyradical production 
(Ferrari et al., 1992). Under conditions of myocardial ischemia, the 
mitochondrial electron transport chain undergoes reduction reactions 
and electrons leak from the chain, therefore, with the reintroduction 
of oxygen, there is excessive formation of oxyradicals (Ferrari et al., 
1992). With a prolonged period of ischemia, endogenous 
mitochondrial antioxidants are depleted and the mitochondria can no 
longer counteract the excessive amounts of oxyradicals (Ferrari et al., 
1992). 
The leukocyte theory of oxyradical formation states that 
polymorphonuclear leukocytes (PMNs) invade ischemic myocardium 
and attack viable myocytes by generating oxyradicals through their 
bacteriocidal mechanisms (Downey, 1990). Activated PMNs can 
adhere to the vascular endothelium, and with reperfusion, release 
oxyradicals that increase vascular permeability and cause myocyte 
death (Lucchesi, 1990). Recall that the catecholamine 
cardiomyopathy is characterized histologically by a monocyte 
inflammatory response, however monocytes are also capable of 
generating the superoxide anion (Halliwell, 1991). Therefore, 

leukocytes are also a plausible source of oxyradicals in the 
catecholamine cardiomyopathy. 
ANTIOXIDANTS: SIJPEROXIDE DISMIJTASE AND CATALASE 
Superoxide dismutase (SOD) and catalase are two enzymatic 
antioxidants that have been used extensively in studies of ischemia- 
reperfusion. SOD catalyzes the dismutation of superoxide anion (O2O 
to hydrogen peroxide (H2O2), and catalase catalyzes the conversion 
of hydrogen peroxide to water (Simpson et al., 1987 and Halliwell, 
1991). The reactions are as follows (Bast et al., 1991 and Halliwell, 
1991): 
202- + 2H+ -SOD-> h2o2 + 02 
2H2O2 -catalase-> 2H2O + 02 
Hydrogen peroxide is toxic only at high concentrations, however it is 
the formation of the hydroxyl radical (0H-) from hydrogen peroxide 
(via the Haber-Weiss or Fenton reaction) in the presence of transition 
ions (iron or copper) that has deleterious consequences (Ferrari et al., 
1991 and Bast et al., 1991). 
Fe-+ + H2O2 -> Fe3 + + OH- + OH~ 
The hydroxyl radical is capable of attacking unsaturated fatty acids 
of membrane phospholipids to form lipid radicals which, with 
reperfusion, can result in lipid peroxidation of membranes (Ferrari et 
al., 1991 and Halliwell, 1991). Therefore, the conversion of hydrogen 

peroxide to water is essential to the integrity of myocardial cell 
membranes. 
Several experiments have shown that SOD and catalase have 
cardioprotective effects in the setting of ischemia-reperfusion injury 
(See Table 1). These studies differ in their protocols, that is the 
antioxidant is administered prior to the ischemic phase of the 
experiment, or prior to the reperfusion phase, and/or during a 
portion of the reperfusion phase. It is evident that comparison of the 
data requires knowledge of the particular protocol, and an 
understanding that the protocols employed from laboratory to 
laboratory will influence the success or failure that each laboratory 
has with a specific antioxidant (Downey & Yellon, 1992). 
Furthermore, these studies actually provide indirect evidence for 
oxyradical involvement in ischemia-reperfusion injury, such that if a 
particular antioxidant provides cardioprotection it is inferred that a 
particular oxyradical caused the myocardial injury (Downey & 
Yellon, 1992). 
Not all experiments with SOD and catalase have resulted in 
cardioprotection (Chi et al., 1989 and Downey & Yellon, 1992). Some 
experiments actually have negative results, because the antioxidant 
does not reach the site of oxyradical production, or the quantity of 
the oxyradical is so great that the antioxidant is prematurely 
exhausted (Burton, 1988 and Downey & Yellon, 1992). It has been 
postulated that the injurious effects of oxyradicals may not only 
occur at the time of reperfusion but may continue minutes to hours 
after reperfusion (Downey & Yellon, 1992). It has been suggested 
that SOD equilibrates slowly from the vascular to the interstitial 

space, and SOD is removed rapidly from the circulation, so 
cardioprotection is a function of adequate pretreatment (Omar & 
McCord, 1991) Therefore, the dosing and method of administration 
of these antioxidants all impact upon the ability to attain positive 
results (Downey & Yellon, 1992). Furthermore, negative results may 
[also] be due to "the elapsed time between the administration of the 
antioxidant and the assessment of tissue injury...".! ! 
The short plasma half-lives of both SOD and catalase, 
approximately 15 minutes, can lead to negative results (Yellon & 
Downey, 1990). To avoid the problem of the short half-life of SOD, 
bovine SOD has been conjugated to polyethylene glycol (PEG) to 
extend its plasma half-life to 30 hours (Chi et al., 1989). Positive 
results obtained with PEG-SOD suggest that the sustained presence of 
SOD can prevent myocyte death due to oxyradicals formed during 
both ischemia and reperfusion (Chi et al., 1989). An experiment with 
conjugated SOD was conducted in isolated (Langendorff model) 
blood-perfused and crystalloid-perfused (that is, the absence of 
oxyradical producing leukocytes) rabbit and rat hearts (Galinanes et 
al., 1992). However, cardioprotection was not afforded in crystalloid- 
perfused rabbit and rat hearts (Galinanes et al., 1992). The authors 
concluded that failure with the crystalloid-perfused hearts may 
mean that the cardioprotection of PEG-SOD may depend on 
endogenous (blood) factors (Galinanes et al., 1992). 
1 1 Liguo Chi, Yasuo Tamura, Paul T. Hoff, Mahender Macha, Kim P. Gallagher, 
M. Anthony Schork, and Benedict R. Lucchesi, "Effect of Superoxidc Dismutase 
on Myocardial Infarct Size in the Canine Heart After 6 Hours of Regional 
Ischemia and Reperfusion: A Demonstration of Myocardial Salvage." 
Circulation Research 1989; 64, p. 674. 

TABLE 1. ISCHEMIA-REPERFUSION INJURY: STUDIES OF 
OXYRADICAL INVOLVEMENT 
Model Antioxidant Cardioprotection 
Langendorff (crystalloid) 
perfused rabbit hearts 
(Omar & McCord, 1991) 
SOD/15 or 50 min 
prior to ischemia 
yes 
Rabbit, in vivo 
(Koerner et al., 1991) 
SOD + CAT/10 min 




Canine, in vivo 
(Richard et al., 1988) 
SOD + CAT/25 min 
prior to ischemia & 
35 min after 
reperfusion 
no 
Canine, in vivo 
(Chi et al., 1989) 
PEG-SOD/15 min 
prior to ischemia 
yes 
Langendorff (blood) 
perfused rabbit & rat 
hearts 
(Galinanes et al., 1992) 
PEG-SOD/1 hr or 12 
to 24 hr prior to 




perfused rabbit & rat 
hearts 
(Galinanes et al.. 1992) 
PEG-SOD/1 hr or 12 
to 24 hr prior to 
ischemia or as a 
reDerfusate additive 
no 
SOD = Superoxide Dismutase, CAT = Catalase, PEG-SOD 
= Polyethylene glycol-Superoxide Dismutase, min = 
minute, hr = hour. 
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Studies have been done that provide direct 




...there is continuous, online, nondestructive 
monitoring of oxygen free radical levels...In 
e n chanced chemiluminescence, a light- 
amplifying substance, such as luminol or 
lucigenin, is added to increase sensitivity. 
These substances, when oxidized by oxygen 
free radicals, emit light with high quantum 
efficiency. Lucigenin in particular is known to 
be very sensitive to the superoxide anion...12 
The validity of chemiluminescence studies for the detection of 
oxyradicals was shown by an in vitro experiment in which 
oxyradicals were generated, and then the abilities of 19 different 
antioxidants to abolish the oxyradical signals were determined (Rao 
et al., 1988). This study provided direct evidence that if SOD alone, 
catalase alone, or SOD and catalase in combination have 
cardioprotective effects, then superoxide anion, hydrogen peroxide, 
or hydroxyl radical may be implicated as the injurious oxyradical 
(Rao et al., 1988). These authors concluded that caution should be 
used in generalizing this in vitro data to in vivo experiments, 
because other endogenous antioxidants may participate in providing 
cardioprotection and hence confound the identification of specific 
oxyradicals (Rao et al., 1988). 
12 Timothy D. Henry, Stephen L. Archer, Daniel Nelson, E. Kenneth Weir, and 
Arthur H. L. From, “Enhanced Chemiluminescence as a Measure of Oxygen- 
Derived Free Radical Generation During Ischemia and Reperfusion.” 
Circulation Research 1990; 67, p. 1454. 

Enhanced chemiluminescence measurements of oxyradical 
myocardial tissue reactions in an isolated Langendorff-perfused rat 
hearts have shown that oxyradicals are involved in ischemia- 
reperfusion injury (See Table 2). Kumar et ah (1990) used luminol- 
enhanced chemiluminescence, and showed significant production of 
oxyradicals (as evidenced by large chemiluminescence signals) 
during both ischemia and reperfusion. Henry et al. (1990) used 
lucigenin-enchanced chemiluminescence, and showed decreased 
signals during ischemia, however significantly increased and 
prolonged signals during reperfusion. Furthermore, 
"...chemiluminescence gradually declined to a steady-state level but 
did not return to baseline after 20 minutes or reperfusion. This 
implies that there is continued increase in [oxyradical] generation 
above baseline."13 Lastly, Henry et ah documented that SOD 
significantly decreased the chemiluminescence signal during 
reperfusion, however SOD did not abolish this signal (Henry et ah, 
1990). These authors suggest that SOD may not have abolished the 
signal, because oxyradicals other than superoxide anion may be 
generated in ischemia-reperfusion, also the dose of SOD used may not 
have been sufficient for the quantity of oxyradicals formed (Henry et 
ah, 1990). In the above experiments, it is important to compare the 
SOD and catalase doses used and the protocols employed to establish 
ischemia-reperfusion. 
13 Henry et ah, p. 1459. 

TABLE 2. ISCHEMIA-REPERFIISION INJURY: DIRECT 
EVIDENCE FOR OXYRADICAL INVOLVEMENT 
Model Antioxidant_Decreased signals 
Chemiluminescence SOD/10 min prior to yes 
(luminol) Langendorff & 30 min after 
perfused rat hearts 
(Kumar et al., 1990) 
ischemia 
Chemiluminescence Catalase/10 min no14 
(luminol) Langendorff prior to & 30 min 
perfused rat hearts 
(Kumar et al., 1990) 
after ischemia 
Chemiluminescence SOD/20 min after yes 
(lucigenin) Langendorff reperfusion and 20 
perfused rat hearts min prior to a second 
(Henry et al., 1990) cycle of ischemia- 
reperfusion. (Also, 
SOD 5 min prior to 
ischemia & 10 min 
into reperfusion.) 
The authors suggest that SOD was effective and catalase was not, because 
ischemia-reperfusion may produce larger quantities of superoxide anion than 
hydrogen peroxide. Also, the chemiluminescence technique may not be as 
sensitive to hydrogen peroxide (Kumar et al., 1990). 

ANTIOXIDANTS: XANTHINE OXIDASE INHIBITORS 
In addition to antioxidants that scavenge oxyradicals, specific 
antioxidants have been chosen for their ability to intercept the 
production of oxyradicals and offer cardioprotection (Downey & 
Yellon, 1992). Xanthine oxidase inhibitors, allopurinol and 
oxypurinol, prevent xanthine oxidase from producing oxyradicals 
(Downey & Yellon, 1992). In the canine model, allopurinol 
pretreatment (18 hours prior to ischemia) has been shown to 
decrease the extent of damage after 90 minutes of ischemia and 6 
hours of reperfusion. (Werns et al., 1986). In the rat heart, acute 
pretreatment with allopurinol provided myocardial protection from 
ischemia-reperfusion injury (Grum et al., 1987). The mechanism of 
action in both of these studies was concluded to be allopurinol's 
inhibition of xanthine oxidase. 
However, not all experimental studies have supported xanthine 
oxidase inhibition as the mechanism of allopurinol action in 
ischemia-reperfusion. Aromatic hydroxylation and deoxyribose 
assays have shown that both allopurinol and oxypurinol can function 
as hydroxyl radical scavengers, where oxypurinol is a more potent 
scavenger than allopurinol (Moorhouse et al., 1987). Furthermore, 
high performance liquid chromatography (HPLC) findings indicate 
that hydroxyl radical attack on allopurinol results in the formation of 
oxypurinol and other products (Moorhouse et al., 1987). Moreover, 
evidence for allopurinol and oxypurinol being oxyradical scavengers 
was presented in the pig model of ischemia-reperfusion (Das et al., 
1987). Even though there is an absence of xanthine oxidase in the 
pig heart, allopurinol and oxypurinol both conferred significant 

exemplified by preservation of ATP levels, supranormal creatine 
ph osphate levels, increased contractility, and increased compliance 
(Das et al., 1987). Lastly, allopurinol and oxypurinol were shown to 
decrease oxyradical signals (as detected by electron paramagnetic 
resonance spectroscopy) in ischemic-reperfused pig left ventricular 
tissue biopsies (Das et al., 1987). This experiment in the pig did 
contradict the findings by Moorhouse et al., in that allopurinol and 
oxypurinol were shown to be ineffective scavengers of superoxide 
anion and hydroxyl radical (instead they were effective at 
scavenging oxyradicals not commonly implicated in ischemia- 
reperfusion injury); and allopurinol was concluded to be a better 
scavenger than oxypurinol (Das et al., 1987). Finally, in isolated 
Langendorff-perfused rat hearts subjected to global ischemia, 
allopurinol provided increased functional recovery, and increased 
levels of post-ischemic ATP and adenine nucleotides (Lasley et al., 
1987). This study suggests that the protective actions of allopurinol 
may be via preservation of the purine pools rather than preventing 
the formation of oxyradicals (Lasley et al., 1987). However, this 
mechanism does not appear to be true for the catecholamine 
cardiomyopathy, because 
"...the mechanical performance of hearts 
isolated immediately following 90 minute of 
NE infusion was impaired, while energy-rich 
phosphate concentrations remained 
unchanged [see Chen & Downing, 1990]. This 
dissociation suggests that preservation of ATP 
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does not explain the protective action of 
allopurinol in these circumstances."15 
In sum, there may not be a universal mechanism of action for 
allopurinol cardioprotection in ischemia-reperfusion (Grum et al., 
1987 and Moorhouse et al., 1987). 
The chemical structure of allopurinol mimics that of purines, 
therefore it can interfere with normal physiologic reactions by 
competitively inhibiting xanthine oxidase (Puett et al., 1987). 
Oxypurinol (or alloxanthine) is a noncompetitive inhibitor of the 
enzyme xanthine oxidase, and hence is better able to compete with 
the elevated levels of substrate, hypoxanthine and xanthine, formed 
in the ischemic myocardium than is allopurinol (Puett et al., 1987). 
Recall that a competitive inhibitor, such as allopurinol, competes with 
the substrate for the active site of the enzyme, hence a competitive 
inhibitor (such as allopurinol) can be overcome by elevated levels of 
a substrate (Werns et al., 1986). Within an organism, the 
administered dose of allopurinol (plasma half-life of 40 minutes) is 
metabolized to oxypurinol (plasma half-life of 18 to 30 hours), 
therefore it is believed that cardioprotection is actually conferred by 
oxypurinol (Werns et al., 1986 and Downey & Yellon, 1992). 
Researchers have realized that the pharmacology of allopurinol 
and oxypurinol (see above) make it clear that experiments of 
ischemia-reperfusion may yield better results if oxypurinol is used 
instead of allopurinol (Holzgrefe & Gibson, 1989). A dog model of 
ischemia-reperfusion was studied with oxypurinol, in order to avoid 
15 Joseph P. Jiang and S. Evans Downing, "Catecholamine Cardiomyopathy: 
Review and Analysis of Pathogenetic Mechanisms." The Yale Journal of 
Biology and Medicine 1990; 63: p. 588. 
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variability in the biochemical conversion of allopurinol to oxypurinol, 
and in the tissue accumulation of oxypurinol (Holzgrefe & Gibson, 
1989) . Beneficial effects of oxypurinol pretreatment were observed 
with respect to ventricular function in acutely ischemic myocardium 
(Holzgrefe & Gibson, 1989). In isolated Langendorff-perfused rabbit 
hearts, subjected to normothermic ischemia (30 minutes) and 
reperfusion, oxypurinol was administered just prior to reperfusion 
(i.e., not as a pretreatment) (Bergsland et al., 1990). In this 
xanthine-oxidase deficient species (Ferrari et al., 1992), oxypurinol 
was shown to decrease the extent of reperfusion injury (Bergsland et 
al., 1990). The author concludes that, in xanthine-oxidase deficient 
animals, oxypurinol may have another mechanism of action 
(Bergsland et al., 1990). 
Another study points out that the rationale for allopurinol 
pretreatment is to provide time for allopurinol to be converted to its 
more potent metabolite oxypurinol (Matsuki et al., 1990). However, 
in order for antioxidants to be of clinical value, they should function 
optimally during ischemia, and hence not be required to be 
administer as a pretreatment (Matsuki et al., 1990). In the acute 
setting of ischemia, allopurinol (a competitive inhibitor) would be 
unable to compete with excessive levels of xanthine and 
hypoxanthine (Puett et al., 1987 and Matsuki et al., 1990). 
Therefore, oxypurinol and allopurinol were given just prior to 
reperfusion, and it was found that oxypurinol could decrease infarct 
size in dogs but allopurinol could not (Matsuki et al., 1990). It was 
concluded that oxypurinol is superior to allopurinol (Matsuki et al., 
1990) . 

Not all studies 
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with oxypurinol have resulted in 
cardioprotection. Oxypurinol studies that administer oxypurinol as a 
single bolus dose fail to protect the myocardium, therefore it has 
been postulated that oxyradical production is not confined to the 
reperfusion period and may occur even after the oxypurinol 
administration is discontinued (Downey & Yellon, 1992). Downey et 
al. is also referring to another study where dogs received oxypurinol 
(25 mg/kg over 5-10 minutes) was administered after 1 hour of 
ischemia, where there was no decrease in infarct size (when 
compared to dogs that received only saline), however there was 
improvement in ventricular function (Puett et al., 1987). These 
authors conclude that the contractility of the ischemic (yet viable) 
myocardium was increased by oxypurinol (Puett et al., 1987). 
However, oxypurinol did not decrease the infarct size. 
Negative results in experiments employing oxypurinol or 
allopurinol may be related to the presence or absence of xanthine 
oxidase in the myocardium of the animal model (Podzuweit et al., 
1991). There is considerable species variation regarding the 
existence of xanthine oxidase in the myocardium (Podzuweit et al., 
1991). Xanthine oxidase, is "an enzyme localized in the vascular 
endothelium,"16 of dogs and rats (Downey & Yellon, 1992), however it 
is not present in sufficient quantities in the hearts of rabbits, pigs, 
and humans (Ferrari et al., 1992). This variation calls into question 
the applicability of experiments done in animal models to humans 
16 R. Ferrari, C. Ceconi, S. Curello, A. Cargnoni, F. De Giuli, and O. Visioli, 
'Occurrence of Oxidalive Stress During Myocardial Rcpcrfusion." Moll Cell 
Biochem 111: 61-69, 1992, p. 62. 

(Podzuweit et al., 1991). In the rat heart a significant quantity of 
xanthine oxidase is present, and rat xanthine oxidase has been 
shown to be inhibited by allopurinol (Podzuweit et al., 1991). An 
isolated Langendorff-perfused rabbit heart study of ischemia- 
reperfusion detected a low concentration of xanthine oxidase, and 
allopurinol effectively inhibited this concentration (Terada et al., 
1991 and Grum et al., 1987). Assays on left ventricular biopsies of 
pig hearts do not reveal detectable levels of xanthine oxidase (Das et 
al., 1987). An in vitro high performance liquid chromatography 
(HPLC) assay of viable, non-ischemic human left ventricular biopsy 
specimens did not detect xanthine oxidase nor its precursor, xanthine 
dehydrogenase, in the human myocardium (Podzuweit et al., 1991). 
These findings do not support the hypothesis that xanthine oxidase is 
a source of oxyradicals in ischemia-reperfusion (Podzuweit et al., 
1991). 
Several of the ischemia-reperfusion studies that attempt to 
implicate oxyradicals as the mediators of the myocardial injury have 
conflicting results. Nevertheless, there are resolved issues regarding 
the possible role of oxyradicals including (a) oxyradicals are toxic to 
myocytes, and (b) oxyradicals are formed during both ischemia and 
reperfusion (Kloner et al., 1989). The unresolved issues include (a) 
which oxyradical is predominant in the ischemia-reperfusion injury 
hypothesis, (b) what is the specific source of oxyradicals in ischemia- 
reperfusion, (c) what is the location of action of antioxidants: in the 
vascular endothelium, in the myocyte, or in the interstitium, and 
lastly (d) what is the role of antioxidants clinically (Kloner et al., 
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The clinical relevance of basic research studies of oxyradicals 
and antioxidants is that of salvaging reversibly-injured myocardium 
and preventing progression of the injury during reperfusion. The 
relevance of the above discussion to the catecholamine 
cardiomyopathy is that the histopathology (namely, monocyte 
infiltration, round cells being chronic inflammatory cells rather than 
acute inflammatory cells, which are PMNs) of this myocarditis 
suggests a pathogenetic role for reperfusion injury. The possibility 
that oxyradicals and reperfusion injury may explain the 
catecholamine cardiomyopathy is the subject of this thesis 
experiment. 

MATERIALS AND METHODS 
I. Infusion Protocol 
New Zealand white rabbits were anesthetized via an ear vein 
injection with pentobarbital sodium (30 mg/kg. Nembutal, Abbott 
Laboratories). The groin hair overlying the femoral triangle was 
shaved. The skin superior to the femoral pulse was anesthetized 
with lidocaine hydrochloride 2% (Tech America). A 3 to 4 cm incision 
was made in the groin and the femoral artery and vein were 
dissected out. The femoral artery was catheterized with 
polyethylene tubing (inside diameter=1.4 mm, outside diameter= 1.57 
mm, Becton Dickinson) and connected to a Hewlett Packard 
Physiograph to monitor heart rate and mean arterial pressure during 
drug infusion. The femoral vein was catheterized with polyethylene 
tubing (inside diameter=0.86 mm, outside diameter=l .27 mm, Becton 
Dickinson) and connected to a Harvard Infusion/Withdrawl Pump 
(Harvard Apparatus Co., Inc., Dover, Mass.) for drug infusion. 
Rabbits were assigned randomly to four groups (see Table 1). 
Group 1 (n=5) was the control group which was infused with 0.9% 
saline (Abbott Laboratories). Group 2 (n=6) was infused with 
Norepinephrine (3 ug/min/kg for 90 minutes, NE, Levophed 
bitartrate, Winthrop Pharmaceuticals). Group 3 (n=7) was infused 
with bovine superoxide dismutase (5 mg/kg/hr, Boehringer 
Mannheim), and bovine catalase (10 mg/kg/hr, Hydrogen Peroxide: 
Hydrogen Peroxide Hydroreductase, Sigma) simultaneously with an 
infusion of NE (3 ug/min/kg for 90 minutes). Group 4 (n=4) was 

pretreated with oxypurinol, 20 mg/kg dissolved in 10 ml 0.9% saline 
(alloxanthine, Sigma).17 Oxypurinol was infused over 10 minutes, 
and then 5 minutes later, NE was infused (3 ug/min/kg over 90 
minutes). 
17 The dosages for SOD, catalase, and oxypurinol used herein arc similar to 
those used in canine and rabbit experiments of cardioprotcction in ischemia- 
reperfusion injury (Jcroudi et al., 1990, Downey et al., 1991, Koerner et al., 
1991, Holzgrefe & Gibson, 1989, Richard et ah, 1988, and Puctt, et ah, 1987). 
Interestingly, Downey et ah, 1991 have shown that the optimal 
cardioprotection by SOD is seen at a dosage of 5 ntg/kg administered as a bolus 
10 minutes prior to reperfusion. 

TABLE 3. RANDOM GROUP ASSIGNMENTS OF RABBITS 
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Arterial pH and P02 and pC02 (IL model 1304 blood gas 
analyzer), hematocrit (HCT, Adams Autocrit Centrifuge), heart rate 
(HR), mean arterial pressure (MAP), and glucose (glucometer. Miles 
Laboratories) were monitored before the start of the infusion, and 
then at intervals during the infusion. The intervals (minutes from 
start of infusion) were 3, 5, 10, 30, 60, 90, and 95 (that is, 5 minutes 
post-infusion). The infusions were stopped at time = 90 minutes. The 
femoral catheters were removed, and the femoral groin incisions 
were sutured closed. Rabbits were returned to their cages to recover 
for 48 hours. 
II. Isolated Langendorff-Perfused Heart Protocol 
After 48 hours, rabbits were anesthetized with pentobarbital 
sodium (30 mg/kg). The hair on the rabbits' neck was shaved. A 
midline incision was made in the neck, and the trachea was dissected 
out. A midline incision was made from the sternal notch to the 
xiphoid process, and endotracheal intubation via a Harvard 
Apparatus Respiration Pump (respiratory rate set at 30 
breaths/minute) was used for ventilation. Heparin (1000 units, i.v.) 
was infused and allowed to circulate for 1 minute. The heart was 
rapidly excised and transferred to ice-cold Krebs-Henseleit 
bicarbonate buffer to attain cardioplegia. The Krebs-Henseleit buffer 
was composed of (concentration measured as millimoles/liter): 
NaCl 1 18.0 KC1 4.7 KH2PO4 1.2 
MgS04 2.4 NaHC03 25.0 CaCl2 2.4 
glucose 5.5 lactate 1.5 

The buffer also contained 250 umol/L free fatty acids and 2% bovine 
serum albumin. 
The heart was hung on an isolated Langendorff-perfused 
apparatus (see Figure 1 and Table 4). The superior and inferior 
vena cavae and the pulmonary veins were ligated with silk sutures. 
A cannula (polyethylene tubing) was placed in the pulmonary artery, 
and the coronary flow was collected from this cannula. A latex 
balloon was inserted into a 1 cm incision in the left atrium, and the 
balloon was connected to a Gould model 3400 recorder and 
transducer (Gould, Inc., Cleveland, Ohio). The transducer monitored 
the HR and hearts were paced at approximately 190 beats/minute. 
(Hearts were paced only if they did not maintain a HR of 190 on 
their own.) The Krebs-Henseleit buffer was used to perfuse the 
hearts at a perfusion pressure of approximately 75 cm H2O. The 
buffer was oxygenated with 95% O2 and 5% CO2. The temperature of 
the hearts was maintained with a water-jacket at 37 degrees Celsius. 
Mechanical function data were obtained from the Langendorff- 
perfused rabbit hearts. After being hung, hearts were given a 15 
minute recovery period. Timed collections of coronary flow were 
made. Peak systolic pressure, maximum rate of rise of left 
ventricular pressure (+dP/dtmax< i.e. contractility), rate of relaxation 
(-dP/dt) were measured at left ventricular end diastolic pressures 
(LVEDP) of 0-2, 5, and 10 cm H2O. These measurements were made 
with the Gould transducer. Myocardial oxygen consumption (MVO2) 
and oxygen extraction were determined from the oxygen content of 
the perfusate samples using the IL model 1304 blood gas analyzer. 

The equations used for the determination of oxygen data were as 
follows: 
pCH = partial pressure of oxygen 
MVOo = (coronary flow) (arterial p02 - venous pO2)/(100) 
MVCH/lOOg = (MVO2)(100)/(total heart weight) 
% O2 extraction = (arterial pCb - venous pCb) (100%)/(arterial p02) 
Coronary Flow/lOOg = (coronary flow)/(total heart weight) 
After all of the mechanical and oxygen data were collected, the 
apex of the left ventricle was freeze-clamped with aluminum tongs 
and stored in liquid nitrogen. This left ventricular sample was used 
for the determination of high energy phosphates, adenosine 
triphosphate (ATP) and creatine phosphate (CP), and glycogen 
(Lowry & Passonneau, 1972 and Seifter et al., 1950). The midsection 
of the left ventricle was sectioned and preserved in formalin for 
















FIGURE 1. ISOLATEDJL A NGENPQRFF- PERFUSED HEART 
APPARATUS (Jiang et al., 1991) 

























Heated heart chamber 
Pressure transducer 
Balloon Cannula and inflation system 
Coronary Flow Cannula from pulmonary artery 
Perfusate reservoir 
Perfusate filter 
Sarns roller pump 
Prevents accidental emptying of system and aids 
precise level control (70 cm H2O) 
O, C, H = Jacketed and circulated with water at 39 Celsius 
by means of Haake water bath 
(Jiang et al., 1991). 

III. STATISTICAL ANALYSIS 
All results were analyzed with Stat View^M 512+ Macintosh 
software (cl986 Abacus Concept, Inc.) on an Apple Macintosh IIci 
computer. ANOVA and unpaired student's t test analyses were 
performed when indicated. Statistical significance was considered 
when p < 0.05. 
TV. CONTRIBUTIONS TO THE EXPERIMENT 
In anticipation of this author's arrival to the laboratory in June 
1990, the technicians performed experiments on six rabbits (R-90- 
21, R-90-23, R-90-25, R-90-27, R-90-29, and R-90-30) to perfect the 
technique of the above protocol. Subsequently these rabbits were 
included in this investigation. All other rabbits (n=16) were 
experimented upon by this author with assistance by the technicians. 
A1 so, the technicians provided assistance in running biochemical 
assays, and performing calculations for the oxygen data. Histologic 
scoring was done independently by both this author and Dr. Downing 
(without knowledge of the particular antioxidant received by any 
rabbit). Statistical analyses were done independently by both this 
author and Dr. Downing. In sum, this author completed the largest 
portion of the experimental work in this thesis. 

RESULTS 
I. MECHANICAU DATA 
Hearts infused with NE only tended to develop lower peak 
systolic left ventricular pressures (PSP) than did the hearts infused 
with saline (see Table 5 and Figure 2). However, the values were not 
significantly different. In hearts treated with superoxide dismutase 
(SOD) or oxypurinol (OXY) and infused with NE, mean PSP values did 
not differ from the saline controls. The hearts infused with NE + OXY 
had mean PSP values lower than the NE only group and NE+SOD/CAT 
group, but these differences did not reach significance. 
Table 5. PEAK SYSTOLIC LEFT VENTRICULAR PRESSURE at 
LVEDP z lfl cm H^O 
Group PSP 
SALINE 93 + 8.6 
NE 73 + 9.6 
NE + SOD/CAT 82 + 7.7 
NE + OXY 67 + 9.6 
PSP = Peak Systolic Pressure. The values are expressed as the mean 
± S.E.M., in units of mmHg. NE = Norepinephrine, SOD/CAT = 
Superoxide dismutase/Catalase, OXY = Oxypurinol. The differences 









MECHANICAL DATA. PSP at LVEDP = 10 cm H2Q 
100 
Figure 2. Peak Systolic Pressure (PSP) at LVEDP = 10 cm FbO- NE = 
Norepinephrine, SOD/CAT = Superoxide Dismutase, OXY= Oxypurinol. 




The maximum rate of increase in ventricular pressure, 
+ dP/dtmax. (a measure of contractility) at left ventricular end 
diastolic pressure (LVEDP) = 10 cm H2O tended to be lower in the NE 
only group (see Table 6 and Figure 3). However, mean values were 
not significantly different from the saline controls or pretreated 
groups. The NE + SOD and NE + OXY groups both had +dP/dtmax 
values that did not differ from the NE only group. 
Table 6. MAXIMUM RATE OF INCREASE IN LEFT 
VENTRICULAR PRESSURE (CONTRACTILITY) at LVEDP = 10 
cm H?0 
Group + d P/dt 
SALINE 1167 + 162.0 
NE 960 + 146.8 
NE+SOD/CAT 1053 + 96.5 
NE + OXY 990 + 129.3 
+dP/dt = maximum rate of increase in pressure. The values 
expressed as mean + S.E.M., in units of mmHg • sec x 10'3. NE = 
Norepinephrine, SOD/CAT = Superoxide dismutase/Catalase, OXY = 






















MECHANICAL DATA. +dP/dt LVEDP=10cm H2Q 
4 5 
Figure 3. Maximum Rate of Increase in Left Ventricular Pressure 
(+dP/dt. i.e. Contractility) at LVEDP = 10 cm H^O . NE = 
Norepinephrine, SOD/CAT = Superoxide dismutase/Catalase, OXY = 




The rate of relaxation of the left ventricle (-dP/dt) in the NE 
group was less than that of the saline controls (see Table 7 and 
Figure 4) and the difference was statistically significant (p < 0.03). 
The rate of relaxation in NE + OXY group was also significantly less 
than that of the saline controls (p < 0.01). There was no significant 
difference between the saline controls and the NE + SOD/CAT group. 
The NE + SOD/CAT group did not differ from the NE only group 
(Figure 4). The NE + OXY group showed relaxation rates which tended 
to be less than the NE only group; however the difference was not 
statistically significant. 
Table 7. RATE OF LEFT VENTRICULAR RELAXATION at 
EVEDP = 10 cm flbO 
Group -dP/dt 
SALINE 1067 + 124.7 
NE 649 + 107.9* 
NE+SOD/CAT 799 + 92.2 
NE + OXY 529 + 45.8* * 
-dP/dt = rate of relaxation. The values are expressed as the mean +_ 
S.E.M. in units of mrnHg • sec x 10'3. NE = Norepinephrine, SOD/CAT = 
Superoxide dismutase/Catalase, OXY = Oxypurinol. * = statistical 
significance versus the saline control group, where * p < 





















MECHANICAL DATA. -dP/dt LVEDP=10cni-H2fl 
1200 
SALINE NE NE+SOD/CAT NE+OXY 
Figure 4. Rate of Left Ventricular Relaxation (- dP/dt) at LVEDP = 10 
cm H^O. NE = Norepinephrine, SOD/CAT = Superoxide 
dismutase/Catalase, OXY = Oxypurinol. NE group, p < 0.05 versus 




II METABOLIC DATA 
Coronary flow in the NE groups was lower than the saline 
control group. NE + SOD/CAT tended to have a higher coronary 
flow than the NE only group. However, this difference was not 
significant. In the NE + OXY group, coronary flow was significantly 
lower than that of the NE + SOD/CAT group (p=0.04), but not 
significantly different from the saline controls or the NE only group. 
Myocardial oxygen consumption was depressed in all of the 
groups infused with NE. The differences between these groups and 
the saline controls did not reach statistical significance. Myocardial 
oxygen consumption did not differ significantly among the three 
groups receiving NE. 
O2 extraction was similar among all four groups. There was n_o 
significant difference between any of the NE treated groups. 
Table 8. METABOLIC DATA: CORONARY FLOW. 
MYOCARDIAL OXYGEN CONSUMPTION, and MYOCARDIAL 
OXYGEN EXTRACTION at LVEDP = 10 cm H?Q 
Group OF MVOo 02 EXT 
SALINE 6.9 + 1.2 7.00 + 1.65 50 + 5.3 
NE 4.2 + 0.5 4.47 + 0.39 55 + 4.0 
NE+SOD/CAT 5.5 + 0.5 4.62 + 0.63 59 6.3 
NE+OXY 3.3 + 0.9 3.27 + 0.32 64 + 0 * 
All values are expressed as mean + S.E.M. CF = Coronary Flow, in 
units of ml/min/g. MVO2 = Myocardial Oxygen Consumption, in units 
of ml/min/lOOg. O2 EXT = Myocardial Oxygen Extraction, in units of 
%. * = statistical significance versus the NE + SOD/CAT group 
(p = 0.04). 

ITT. BIOCHEMICAL DATA 
Adenosine triphosphate (ATP) concentrations did not differ 
significantly between the saline control group and the NE treated 
groups (see Table 9). Within the NE treated groups, ATP 
concentration was significantly different between the NE only group 
and the NE + OXY group (p=0.01), however there was no significant 
difference between the NE + SOD/CAT group and the NE + OXY group. 
Creatine phosphate (CP) concentration differed significantly 
between the saline control group and the NE + OXY group (p=0.03), 
and between the NE + SOD/CAT and NE + OXY groups (p=0.04), 
however not between the NE and NE + OXY groups. 
Myocardial glycogen concentration did not differ significantly 
among the four groups, nor between the NE treated groups. 
Table 9. BIOCHEMICAL DATA: PRESERVATION OF HIC.H 
ENERGY PHOSPHATES AND GLYCOGEN 
GROUP ATP CP GLYCOGEN 
SALINE 18 + 3.1 32 + 5.4 122 + 14.9 
NE 16 + 1.1 39 + 8.9 115 +_ 20.4 
NE + SOD/CAT 15 + 1.9 39 + 6.0 151 + 25.2 
NE + OXY 10 + 0.7* 69 + 13.6** 90 ■+ 19.5 
All values are expressed as mean +_ S.E.M., in units of 
micromoles/gram dry weight. ATP = Adenosine triphosphate, CP = 
Creatine phosphate, NE = Norepinephrine, SOD/CAT = Superoxide 
dismutase/Catalase, OXY = Oxypurinol. * = statistical significance 
versus NE group, where p = 0.01, and ** = statistical 
significance versus the saline control group, p = 0.03, and 
the NE + SOD/CAT group, p = 0.04. 

TV. HISTOLOGICAL DATA 
The NE only group showed histopathological damage that 
differed significantly from the saline control group with p=0.04 (see 
Table 10 and Figure 5). Also the NE + SOD/CAT and NE + OXY groups 
both differed significantly from the saline group (p = 0.04 and p < 
0.01, respectively). However, there was no difference between any 
of the NE treated groups. 
Table 10. HISTOLOGICAL DATA: Hematoxylin and Eosin 
stained left v entricular microscoDie sections 
GROUP SCORE Significance (vs. Saline) 
SALINE 0.4 + 0.3 — 
NE 1.4 + 0.2 P = 0.04 
NE + SOD/CAT 1.4 + 0.2 P = 0.04 
NE + OXY 1.9 + 0.1 D < 0,01 
Histologic scores represent 0 (no evidence of histologic abnormality) 
0.5 (equivocal focal lesions), 1.0 (definite but sparse lesions), 1.5 (less 
intense than 2.0 but greater than 1.0), and 2.0 (florid and 
widespread lesions) (Downing, 1978). These sections were scored by 
2 observers unaware of the treatment group, and the two scores for 
each rabbit heart were averaged. The mean values are shown below 
as mean ±_ S.E.M. NE = Norepinephrine, SOD/CAT = Superoxide 
dismutase/Catalase, OXY = Oxypurinol. There was no significant 
difference in the histological changes seen between NE group 
(p=0.11) or NE + SOD/CAT group (p=0.12) versus NE + OXY group. 

HISTOLOGY 
SALINE NE NE+SOD/CAT NE+OXY 
Figure 5. Histological Data. Left Ventricular Sections. NE = 
Norepinephrine, SOD/CAT = Superoxide dismutase, OXY = Oxypurinol. 
NE group, p = 0.04 versus saline control group; NE + 
SOD/CAT group, p = 0.04 versus saline control group; and 
NE + OXY group, p < 0.01 versus saline control group. 

DISCUSSION and CONCLUSION 
The purpose of this study was to test the hypothesis that 
oxyradicals mediate the myocardial pathology that characterizes 
catecholamine cardiomyopathy. A previous study performed in our 
laboratory showed that allopurinol, a xanthine oxidase inhibitor, 
protected the myocardium from cardiomyopathic changes due to the 
infusion of norepinephrine (Jiang et al., 1991). The mechanism of 
allopurinol's cardioprotection is unknown. In the rabbit, a xanthine 
oxidase-deficient species (Ferrari et al., 1992), the mechanism is not 
likely to be the inhibition of xanthine oxidase-generated oxyradicals 
(Podzuweit et al., 1991 and Jiang et al., 1991). Direct evidence for 
the oxyradical scavenging abilities of allopurinol, and its major 
metabolite oxypurinol (OXY), has been published (Moorhouse et al., 
1987). Therefore, it has been suggested that the mechanism of 
cardioprotection by allopurinol in catecholamine cardiomyopathy 
may involve the direct scavenging of oxyradicals ( Das et al., 1987 
and Jiang et al., 1991). With this in mind, the present study was 
undertaken to seek evidence for oxyradical-mediated injury in the 
cardiomyopathic rabbit hearts. 
Superoxide dismutase (SOD) and catalase were initially chosen 
for this study because these well-known antioxidants have provided 
cardioprotection in m vivo models of reperfusion injury (Koerner et 
al., 1991). Oxypurinol was also examined, because it is a more 
potent antioxidant than allopurinol. Allopurinol is rapidly converted 
to oxypurinol m vivo (Werns, 1986). Therefore, it was hypothesized 
that pretreatment with oxypurinol, the antioxidant most likely to 

provide the cardioprotection (Werns, 1986), would be effective. 
However, the results of this study provide evidence against 
oxyradical involvement in the pathogenesis of this cardiomyopathy. 
The mechanical data show that all of the norepinephrine (NE) 
treated groups developed lower left ventricular peak systolic 
pressures (PSP) than did the saline control group. This decreased PSP 
provides functional evidence for NE injury in the rabbit hearts in 
these groups. This is important because the histologic scores of the 
NE only group and the NE + SOD/CAT group were both somewhat 
lower (1.4 +_ 0.2) than the expected 2.0. This left some question as to 
whether or not the NE infusion was adequate. However, the reduced 
mechanical function suggests that an adequate quantity of NE 
reached the hearts. (The use of a larger number of rabbits may 
actually have resulted in a statistically significant difference in PSP 
and +dP/dt between controls and NE treated groups; and this 
difference in mechanical function may have been reflected in 
histologic scores closer to the expected value of 2.0.) In contrast, 
the group that received NE + OXY had an average histologic score of 
1.9 +_ 0.1, indicating severe NE-induced cardiomyopathy. All of the 
NE treated hearts had histologic scores that were significantly higher 
than the average score of the saline control hearts. 
The maximum rate of increase in left ventricular pressure 
(contractility, +dP/dt) did not differ significantly among the groups. 
However, the rate of left ventricular relaxation (-dP/dt) did differ 
significantly between the saline control group and both the NE only 
group and NE + OXY group. These data also attest to adequate NE 
reaching the myocardium. The NE + OXY group showed extensive 

myofiber damage both histologically and functionally. Moreover, it 
suggests that oxypurinol may have had a deleterious effect rather 
than affording protection for these rabbit hearts. 
The oxygen data reveal that coronary flow was depressed in all 
NE treated groups, although less severe depression was observed in 
the NE + SOD/CAT group. Myocardial oxygen consumption tended to 
be lower in all the NE groups, although mean values were not 
significantly different from the saline controls. Importantly, oxygen 
extraction was maintained in all four groups (as seen in the previous 
allopurinol experiment), and the NE + OXY group showed increased 
oxygen extraction. 
The high energy phosphate data show that there was a 
significant difference in the preservation of ATP between the NE only 
group and the NE + OXY group. Again, this suggests that oxypurinol 
may have negative effects on the myocardial energy stores. Creatine 
ph osphate also differed significantly between these groups, and 
between the saline control and the NE + OXY group. The fact that 
there was no change in glycogen concentration among the groups is 
inconsistent with the allopurinol data, where NE was shown to 
decrease the myocardial glycogen content by 70% (Jiang et al., 1991). 
Only the NE + OXY group showed a tendency for decreased glycogen 
content, although not significantly. In sum, it appears that the 
combination of NE + OXY had a more deleterious effects on the 
myocardium than the administration of NE alone. 
With respect to the hypothesis that oxyradicals mediate 
injury in catecholamine cardiomyopathy, the reason why the 
antioxidants used in this study did not protect the rabbits hearts 

could be found in the method of drug administration. SOD and 
catalase were infused simultaneously with the NE. However, SOD 
requires time for equilibration between the vascular space and the 
myocardial interstitium (Omar & McCord, 1991). Hence, the approach 
used in this study may not have allowed sufficient time for 
equilibration to occur. Also, the amount of SOD and catalase used 
may not have been adequate for the quantity of oxyradicals 
generated during NE infusion. 
Oxypurinol treatment was not applied in this study in the same 
manner as in the previous allopurinol study. In the latter, 
allopurinol was infused intravenously for 3 minutes, and then 30 
minutes later, allopurinol and NE were infused simultaneously (Jiang 
et al., 1991). This approach would have allowed time for oxypurinol 
to be formed from allopurinol. In the present study, it was assumed 
that direct administration of oxypurinol would not require a 3 
minute pretreatment period. However, this assumption may have 
been incorrect. The in vivo conversion of allopurinol to oxypurinol 
may be necessary to activate other endogenous factors that may 
contribute to the cardioprotective mechanism of action of these 
xanthine oxidase inhibitors. 
In conclusion, the data obtained in this study suggest that 
oxyradicals do not play a role in the pathogenesis of catecholamine 
cardiomyopathy in the rabbit model. This is an important negative 
finding, because it calls into question the proposed protective 
mechanism of allopurinol in NE-cardiomyopathy and in myocardial 
ischemia-reperfusion injury explored in several animal models 
(Werns et al., 1986 and Das et al., 1987). Furthermore, these 

findings are important in that the oxyradical hypothesis of 
catecholamine injury is not supported, and the mechanistic basis for 
the pathogenesis of the catecholamine cardiomyopathy remains 
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